DR. CALLEBAUT - DR. ORLANS
ActiveSummary
DR. CALLEBAUT - DR. ORLANS has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €984k and a net result of €189k. Equity is growing by ~15.3% per year across the filed fiscal years. Its solvency ranks better than 44% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
86
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability84=
Solvency87▲+2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €80k at 30 days acceptable
Liquidity ample (current ratio 2.61 against 3.03 in 2023; short-term debt: 19.9% and cash: 27.1% of total assets), and 38.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
61.9%
Return on assets
11.9%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 03-07-2025, 28 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
28 d early
2023
27 d early
2022
25 d early
2021
29 d late
2020
9 d early
2019
25 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€984k▲ 13.1%
2023 · €869k
2018: €469k
2019: €483k
2020: €556k
2021: €645k
2022: €790k
2023: €869k
2018 → 2024
Total assets
€1.59M▲ 9.0%
2023 · €1.46M
2018: €810k
2019: €814k
2020: €833k
2021: €915k
2022: €1.04M
2023: €1.46M
2018 → 2024
Net result
€189k▲ 3.7%
2023 · €183k
2018: €77k
2019: €116k
2020: €135k
2021: €204k
2022: €145k
2023: €183k
2018 → 2024
Working capital
€509k▼ 8.0%
2023 · €553k
2018: €225k
2019: €250k
2020: €340k
2021: €370k
2022: €543k
2023: €553k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€556k-€645k▲ 15.9%€790k▲ 22.5%€869k▲ 10.1%€984k▲ 13.1%
Operating result€209k-€288k▲ 37.9%€238k▼ 17.5%€264k▲ 11.0%€289k▲ 9.7%
Net result€135k-€204k▲ 50.9%€145k▼ 28.8%€183k▲ 25.9%€189k▲ 3.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 10% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.59M
Fixed assets
€763k ▲ 20.6%
Current assets
€825k =
Equity and liabilities €1.59M
Equity
€984k ▲ 13.1%
Debt
€605k ▲ 2.8%
Debt's share of the balance-sheet total falls from 40.4% to 38.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€345k▲
2023 · €312k
Cash flow
€245k▲
2023 · €231k
Current ratio
2.61▼
2023 · 3.03
Debt to equity
0.62▼
2023 · 0.68
ROE
19.3%▼
2023 · 21.0%
ROA
11.9%▼
2023 · 12.5%
Interest coverage
16.10▼
2023 · 155.66
Debt ≤ 1 year
€317k▲
2023 · €272k
Debt > 1 year
€276k▼
2023 · €317k
Income taxes
€83k▲
2023 · €80k
Staff costs
€5k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 51 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.46M€1.59M▲
Fixed assets21/28€633k€763k▲
Tangible fixed assets22/27€633k€763k▲
Land and buildings22€360k€347k▼
Plant, machinery and equipment23€16k€15k▼
Furniture and vehicles24€50k€82k▲
Other tangible fixed assets26€111k€92k▼
Assets under construction and advance payments27€97k€227k▲
Current assets29/58€825k€825k=
Amounts receivable within one year40/41€84k€25k▼
Other amounts receivable41€84k€25k▼
Current investments50/53€191k€368k▲
Cash at bank and in hand54/58€549k€430k▼
Deferred charges and accrued income490/1-€2k
Equity and liabilities
Total equity and liabilities10/49€1.46M€1.59M▲
Equity10/15€869k€984k▲
Contributions10/11€6k€6k=
Reserves13€863k€977k▲
Distributable reserves133€863k€977k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€589k€605k▲
Amounts payable after more than one year17€317k€276k▼
Financial debts170/4€317k€276k▼
Amounts payable within one year42/48€272k€317k▲
Current portion of amounts payable after more than one year42€47k€41k▼
Trade debts44€894€970▲
Suppliers440/4€894€970▲
Taxes, remuneration and social security45€69k€70k▲
Taxes450/3€69k€69k▼
Remuneration and social security454/9-€1k
Other amounts payable47/48€155k€204k▲
Accrued charges and deferred income492/3€0€13k▲
Income statement
Code20232024
Remuneration, social security and pensions62-€5k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€48k€55k▲
Other operating charges640/8€2k€2k▼
Gross operating margin9900€314k€351k▲
Operating profit (loss)9901€264k€289k▲
Financial income75/76B€466€5k▲
Recurring financial income75€466€5k▲
Financial charges65/66B€2k€21k▲
Recurring financial charges65€2k€21k▲
Profit (loss) for the period before taxes9903€262k€273k▲
Income taxes67/77€80k€83k▲
Profit (loss) for the period9904€183k€189k▲
Profit (loss) for the period to be appropriated9905€183k€189k▲
Appropriation of the result
Profit (loss) to be appropriated9906€183k€189k▲
Transfer from equity791/2€103k€75k▼
Transfer to equity691/2€183k€189k▲
To other reserves6921€183k€189k▲
Profit to be distributed694/7€103k€75k▼
Return on contributions (dividend)694€103k€75k▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
04-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 29 days late
2021
31-12
Financial
Highest result since 2018net €204k ▲50.9%
Net result €204k, the highest in the series.
22-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Equity above €500kEq €556k ▲15.3%
3 profitable years in a row build equity to €556k.
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
21-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
14-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
29-06
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jabbeke · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gistelsteenweg 5228490 JabbekeGround area
287 m²
Building footprint
287 m²
Volume, LiDAR
1,580 m³
Parcel 31041A0483/00F005, Flanders · tallest building 10.3 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
DR. CALLEBAUT - DR. ORLANS
since 20082.264.219.233
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31041A0483/00F005 | Flanders | 287 m² | 1 · 287 m² | 10.3 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CABINET MEDICAL DES DOCTEURS COMELIAU ET DETRY
BE 0845.570.477
Jalhay · Eq €984,037
DOKTER VANDEWAL
BE 0870.942.313
Brugge · Eq €984,385
DOKTER HASSAN KAYS
BE 0830.994.050
Antwerpen · Eq €984,547
INGELAERE JAN HUISARTS
BE 0876.458.742
Zonnebeke · Eq €982,373
Dokter Maxime Borreman
BE 0545.873.339
Sint-Truiden · Eq €986,222
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,083 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-08-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.